Safety and clinical activity results from a phase Ib study of alectinib plus atezolizumab in ALK plus advanced NSCLC (aNSCLC). Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Kim, Dong-Wan; Gadgeel, Shirish M.; Gettinger, Scott N.; Riely, Gregory J.; Oxnard, Geoffrey R.; Mekhail, Tarek; Schmid, Peter; Dowlati, Afshin; Heist, Rebecca Suk; Wozniak, Antoinette J.; Hernandez, Genevive; Sarkar, Indrani; Mitry, Emmanuel; Foster, Paul; O'Hear, Carol; Spahn, Jessica; Ou, Sai-Hong Ignatius

authors

Publication Date

  • May 20, 2018

webpage

published in

category

volume

  • 36

issue

  • 15